What The White House Is NOT Telling You About The "Green Revolution."
Governments across the globe want to go "All Electric" by 2035. There's one rare metal that could cripple these plans. Without it, going green is impossible. And that's why there's a modern-day gold-rush for this rare metal.
Read The Full Story On This "Gold Rush"

SCPS Insider Trading (Scopus BioPharma)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $73,642.20
Insider Selling (Last 12 Months): $0.00

Scopus BioPharma Insider Trading History Chart

This chart shows the insider buying and selling history at Scopus BioPharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Scopus BioPharma Share Price & Price History

Current Price: $3.91
Price Change: Price Increase of +0.08 (2.09%)
As of 10/19/2021 01:00 AM ET

This chart shows the closing price history over time for SCPS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
What The White House Is NOT Telling You About The "Green Revolution."
Governments across the globe want to go "All Electric" by 2035. There's one rare metal that could cripple these plans. Without it, going green is impossible. And that's why there's a modern-day gold-rush for this rare metal.
Read The Full Story On This "Gold Rush"

Scopus BioPharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/26/2021Joshua R. LamsteinChairmanBuy200$4.90$980.00View SEC Filing Icon  
8/23/2021Ira Scott GreenspanChairmanBuy500$4.41$2,205.00View SEC Filing Icon  
8/19/2021Ira Scott GreenspanChairmanBuy2,000$4.04$8,080.0081,790View SEC Filing Icon  
8/17/2021Ira Scott GreenspanChairmanBuy1,000$4.13$4,130.00View SEC Filing Icon  
7/26/2021Ira Scott GreenspanChairmanBuy400$4.76$1,904.00View SEC Filing Icon  
7/23/2021Ira Scott GreenspanChairmanBuy1,100$4.77$5,247.00118,797View SEC Filing Icon  
2/24/2021Ira Scott GreenspanChairmanBuy115$9.48$1,090.2080,790View SEC Filing Icon  
2/24/2021Robert J GibsonVice ChairmanBuy150$9.46$1,419.00150View SEC Filing Icon  
2/22/2021Joshua R. LamsteinChairmanBuy100$9.99$999.00116,797View SEC Filing Icon  
2/18/2021Ira Scott GreenspanChairmanBuy2,200$10.04$22,088.0080,475View SEC Filing Icon  
2/16/2021Ira Scott GreenspanChairmanBuy2,500$10.20$25,500.0080,475View SEC Filing Icon  
See Full Table
Insider Selling at Scopus BioPharma?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Scopus BioPharma and related companies.

SEC Filings (Institutional Ownership Changes) for Scopus BioPharma (NASDAQ:SCPS)

0.83% of Scopus BioPharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SCPS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Scopus BioPharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/12/2021JPMorgan Chase & Co.9,338$67K0.0%-54.5%0.059%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC23,450$0.17M0.0%N/A0.149%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC92,104$0.78M0.0%N/A0.000%Search for SEC Filing on Google Icon
5/18/2021California State Teachers Retirement System8,365$71K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada3,592$30K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp47,633$0.40M0.0%N/A0.000%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC52,159$0.44M0.0%N/A0.000%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.20,527$0.17M0.0%N/A0.000%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund8,705$74K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.108,237$0.92M0.0%N/A0.000%Search for SEC Filing on Google Icon
5/7/2021American International Group Inc.3,232$27K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC16,280$0.24M0.0%N/A0.000%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Its lead development programs are immuno-oncology gene therapy for the treatment of various cancers, which include CO-sTiRNA, a STAT3 inhibitor gene therapy that drives tumor cell growth and anti-tumor immune suppression; and MRI-1867, a cannabinoid-1 receptor inverse agonist and inhibitor of inducible nitric oxide synthase for the treatment of systemic sclerosis. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.
Read More on Scopus BioPharma

Today's Range

Now: $3.91
Low: $3.82
High: $3.94

50 Day Range

MA: $4.68
Low: $3.83
High: $6.05

52 Week Range

Now: $3.91
Low: $3.79
High: $47.86

Volume

39,934 shs

Average Volume

475,002 shs

Market Capitalization

$70.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Scopus BioPharma?

Scopus BioPharma's top insider shareholders include:
  1. Ira Scott Greenspan (Chairman)
  2. Joshua R Lamstein (Chairman)
  3. Robert J Gibson (Vice Chairman)
What The White House Is NOT Telling You About The "Green Revolution."
Governments across the globe want to go "All Electric" by 2035. There's one rare metal that could cripple these plans. Without it, going green is impossible. And that's why there's a modern-day gold-rush for this rare metal.
Read The Full Story On This "Gold Rush"